Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.77 |
| ▸ | PPARA | Q07869 | 3/20 | 0.61 |
| ▸ | PLA2G4B | P0C869 | 5/20 | 0.58 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.58 |
| ▸ | ALB | P02768 | 1/20 | 0.57 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | PPARG | P37231 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7691552 | 1.00 | L3MBTL1 (0.77) | L3MBTL1PPARAPLA2G4BFFAR4ALB | |
| SCHEMBL29335714 | 1.00 | L3MBTL1 (0.77) | L3MBTL1PPARAPLA2G4BFFAR4ALB | |
| SCHEMBL8357754 | 1.00 | L3MBTL1 (0.77) | L3MBTL1PPARAPLA2G4BFFAR4ALB | |
| SCHEMBL13450803 | 1.00 | L3MBTL1 (0.77) | L3MBTL1PPARAPLA2G4BFFAR4ALB | |
| SCHEMBL4257143 | 0.98 | L3MBTL1 (0.79) | L3MBTL1PPARAPLA2G4BFFAR4ALB | |
| SCHEMBL6883728 | 0.93 | L3MBTL1 (0.82) | L3MBTL1PPARAPLA2G4BFFAR4TSHR | |
| SCHEMBL31448424 | 0.91 | PPARA (0.71) | L3MBTL1PPARAPLA2G4BALBGAA | |
| SCHEMBL29141429 | 0.91 | PPARA (0.71) | L3MBTL1PPARAPLA2G4BALBGAA | |
| SCHEMBL21073528 | 0.91 | PPARA (0.71) | L3MBTL1PPARAPLA2G4BALBGAA | |
| SCHEMBL31448470 | 0.89 | PPARA (0.73) | L3MBTL1PPARAPLA2G4BALBGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7196080-B2 | Respiratory system disordeers; chronic obstructive pulminary disease | ASTELLAS PHARMA INC. (JP) | 2007-03-27 | — | — | US | disclosed |